243 related articles for article (PubMed ID: 18554757)
1. Residual enzymatic activity of the tetanus toxin light chain present in tetanus toxoid batches used for vaccine production.
Behrensdorf-Nicol HA; Kegel B; Bonifas U; Silberbach K; Klimek J; Weiber K; Krämer B
Vaccine; 2008 Jul; 26(31):3835-41. PubMed ID: 18554757
[TBL] [Abstract][Full Text] [Related]
2. Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: applicability as alternative method for the safety testing of tetanus toxoids during vaccine production.
Behrensdorf-Nicol HA; Bonifas U; Hanschmann KM; Krämer B; Weißer K
Vaccine; 2013 Dec; 31(52):6247-53. PubMed ID: 24156922
[TBL] [Abstract][Full Text] [Related]
3. In vitro determination of specific toxicity in tetanus vaccines.
Kegel B; Bonifas U; Silberbach K; Krämer B; Weisser K
Dev Biol (Basel); 2002; 111():27-33. PubMed ID: 12678222
[TBL] [Abstract][Full Text] [Related]
4. Application of an in vitro endopeptidase assay for detection of residual toxin activity in tetanus toxoids.
Leung T; Corran PH; Gee C; Ekong TA; Sesardic D
Dev Biol (Basel); 2002; 111():327-32. PubMed ID: 12678257
[TBL] [Abstract][Full Text] [Related]
5. "BINACLE" assay for in vitro detection of active tetanus neurotoxin in toxoids.
Behrensdorf-Nicol HA; Weisser K; Krämer B
ALTEX; 2015; 32(2):137-42. PubMed ID: 25769344
[TBL] [Abstract][Full Text] [Related]
6. In vitro determination of tetanus toxicity by an endopeptidase assay linked to a ganglioside-binding step.
Behrensdorf-Nicol HA; Bonifas U; Kegel B; Silberbach K; Krämer B; Weisser K
Toxicol In Vitro; 2010 Apr; 24(3):988-94. PubMed ID: 20036726
[TBL] [Abstract][Full Text] [Related]
7. An in vitro assay for detection of tetanus neurotoxin activity: using antibodies for recognizing the proteolytically generated cleavage product.
Kegel B; Behrensdorf-Nicol HA; Bonifas U; Silberbach K; Klimek J; Krämer B; Weisser K
Toxicol In Vitro; 2007 Dec; 21(8):1641-9. PubMed ID: 17826026
[TBL] [Abstract][Full Text] [Related]
8. Results of an international transferability study of the BINACLE (binding and cleavage) assay for in vitro detection of tetanus toxicity.
Behrensdorf-Nicol HA; Bonifas U; Isbrucker R; Ottiger H; Tierney R; Hanschmann KM; Weisser K; Krämer B
Biologicals; 2014 Jul; 42(4):199-204. PubMed ID: 24882365
[TBL] [Abstract][Full Text] [Related]
9. Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin.
Indrawattana N; Sookrung N; Kulkeaw K; Seesuay W; Kongngoen T; Chongsa-nguan M; Tungtrongchitr A; Chaicumpa W
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):85-93. PubMed ID: 20527521
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the detoxification mechanism of formaldehyde-treated tetanus toxin.
Thaysen-Andersen M; Jørgensen SB; Wilhelmsen ES; Petersen JW; Højrup P
Vaccine; 2007 Mar; 25(12):2213-27. PubMed ID: 17240009
[TBL] [Abstract][Full Text] [Related]
11. Targeting the epithelial SNARE machinery by bacterial neurotoxins.
Proux-Gillardeaux V; Galli T
Methods Mol Biol; 2008; 440():187-201. PubMed ID: 18369946
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical and immunochemical assays for monitoring consistent production of tetanus toxoid.
Metz B; Tilstra W; van der Put R; Spruit N; van den Ijssel J; Robert J; Hendriksen C; Kersten G
Biologicals; 2013 Jul; 41(4):231-7. PubMed ID: 23726755
[TBL] [Abstract][Full Text] [Related]
13. Metallopeptidase inhibitors of tetanus toxin: A combinatorial approach.
Martin L; Cornille F; Turcaud S; Meudal H; Roques BP; Fournié-Zaluski MC
J Med Chem; 1999 Feb; 42(3):515-25. PubMed ID: 9986722
[TBL] [Abstract][Full Text] [Related]
14. A conformational change of C fragment of tetanus neurotoxin reduces its ganglioside-binding activity but does not destroy its immunogenicity.
Yu R; Yi S; Yu C; Fang T; Liu S; Yu T; Song X; Fu L; Hou L; Chen W
Clin Vaccine Immunol; 2011 Oct; 18(10):1668-72. PubMed ID: 21813664
[TBL] [Abstract][Full Text] [Related]
15. Transynaptic effects of tetanus neurotoxin in the oculomotor system.
González-Forero D; Morcuende S; Alvarez FJ; de la Cruz RR; Pastor AM
Brain; 2005 Sep; 128(Pt 9):2175-88. PubMed ID: 15987757
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of soluble recombinant tetanus neurotoxin Hc in Escherichia coli as a tetanus vaccine candidate.
Yu R; Hou L; Yu C; Liu S; Ren J; Fang T; Zhang X; Chen W
Immunobiology; 2011 Apr; 216(4):485-90. PubMed ID: 20888666
[TBL] [Abstract][Full Text] [Related]
17. Is the test for irreversibility of tetanus toxoids still relevant?
Behrensdorf-Nicol HA; Krämer B
Vaccine; 2019 Mar; 37(13):1721-1724. PubMed ID: 30826145
[TBL] [Abstract][Full Text] [Related]
18. Affinity chromatography of tetanus toxin, tetanus toxoid, and botulinum A toxin on synaptosomes, and differentiation of their acceptors.
Habermann WE
Naunyn Schmiedebergs Arch Pharmacol; 1976; 293(1):1-9. PubMed ID: 948349
[TBL] [Abstract][Full Text] [Related]
19. Recombinant and truncated tetanus neurotoxin light chain: cloning, expression, purification, and proteolytic activity.
Tonello F; Pellizzari R; Pasqualato S; Grandi G; Peggion E; Montecucco C
Protein Expr Purif; 1999 Mar; 15(2):221-7. PubMed ID: 10049679
[TBL] [Abstract][Full Text] [Related]
20. Beta-amino-thiols inhibit the zinc metallopeptidase activity of tetanus toxin light chain.
Martin L; Cornille F; Coric P; Roques BP; Fournié-Zaluski MC
J Med Chem; 1998 Aug; 41(18):3450-60. PubMed ID: 9719598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
